You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK)旗下两企引资高瓴资本 下午复牌
阿思达克 05-14 12:27
金斯瑞生物科技(01548.HK)公布,公司与投资者高瓴资本管理就公司间接全资附属Probio Cayman建议A轮融资订合约细则。公司将於Probio A轮融资完成前透过其附属Probio BVI认购金额为7,000万美元可转换为Probio股份的可换股债券。而高瓴资本将认购A轮融资总投资额1.5亿美元的Probio Cayman A类优先股。

公司将向高瓴资本发行Probio认股权证,可於Probio A轮融资完成起计24个月内行使,以按等於初始购买价1.32倍的每股价格(最多合共1.25亿美元)购买Probio认股权证股份。

A轮融资完成後,公司全资附属Probio BVI於Probio Cayman的股权将摊薄至82.95%(假设可换股债券未转换为Probio股份)。

另外,公司持股的传奇生物同意向买方LGN Holdings(唯一投资管理人为高瓴资本管理)发行及出售合共近2,081万股传奇股份,总代价为3亿美元;及向买方发行认股权证,可向传奇生物认购及购买最多合共1,000万股传奇股份,总行使价为2亿美元。完成後,公司於传奇生物的股权将由64.31%,摊薄至58.31%。

Probio Cayman拟将A轮融资所得款项净额用作营运资金,主要用於扩大生产设施、加强研发平台以及一般企业开支。传奇生物拟将购买事项所得款项净额用作营运资金,主要用於研发及商业化其管线项目及扩大生产设施、加强研发平台以及一般企业开支。

应公司要求,公司股份已自今日(14日)上午9时正起短暂停牌。公司已向联交所申请本公司股份自今日下午恢复买卖。(ek/u)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account